How AI can help to tackle COVID-19
![Untitled design (2)](https://i3health.eu/wp-content/uploads/2021/03/Untitled-design-2-150x150.png)
Loubna Bouarfa
CEO, Okra Technologies, Cambridge, UK
![Untitled design (3)](https://i3health.eu/wp-content/uploads/2021/03/Untitled-design-3-150x150.png)
Michel Bouvier
CEO, Institute for Research in Immunology and Cancer, Université de Montréal, Canada
![Untitled design (4)](https://i3health.eu/wp-content/uploads/2021/03/Untitled-design-4-150x150.png)
Giovanni Briganti
Senior fellow, I3h Institute, Université libre de Bruxelles, Belgium
![Michel Goldman](https://i3health.eu/wp-content/uploads/2020/03/Michel-Goldman-150x150.jpg)
Michel Goldman
Founder of the I3h Institute
![Untitled design (5)](https://i3health.eu/wp-content/uploads/2021/03/Untitled-design-5-150x150.png)
Philippe Moingeon
Head of Immuno-inflammation, Servier Pharmaceuticals, Neuilly-sur-Seine, France